The Clinical Study To Evaluate The Efficacy Of Mrudvikadi Churna In Tundikeri (tonsilitis)in childern

The Clinical study to evaluate the efficacy of Mrudvikadi Churna in Tundikeri

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027718

Enrollment

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

Intervention1: Mrudvikadi churna ( triphala trikatu manuka patha murva tejovati kutki daruharidara motha): Total numbers of 35patients will be selected from the age group between 4to10 year suffering

Eligibility

Inclusion criteria

Inclusion criteria: Childern suffering from tundikeri Age limit from 4-10 years Childern and parents willing from trial

Exclusion criteria

Exclusion criteria: Childern suffering from chronic tundikeri. Patient refuses to take treatment.

Design outcomes

Primary

Measure	Time frame
To treat the children with tundikeri with Mrudvikadi churna which is more safe and side effect free as compare to modern antibioticsTimepoint: 7 Days study ( 0,3,7 days )	—

Secondary

Measure	Time frame
To treat the children with tundikeri with Mrudvikadi churna which is more safe and side effect free as compare to modern antibioticsTimepoint: 7 days study with two follow up ( 0,3,7 days )	—

Countries

India

Contacts

Public ContactDr Ravindra diliprao chhabile

Dr D Y PAtil college of Ayurved and research centre pimpri

Ravirajpal24@gmail.com9922037201

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026